| Product Code: ETC4746558 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Antimalarial Drugs Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Antimalarial Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Antimalarial Drugs Market - Industry Life Cycle |
3.4 Latvia Antimalarial Drugs Market - Porter's Five Forces |
3.5 Latvia Antimalarial Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Latvia Antimalarial Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Antimalarial Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of malaria in Latvia |
4.2.2 Growing awareness and initiatives for malaria prevention and treatment |
4.2.3 Government support and funding for healthcare infrastructure and programs |
4.3 Market Restraints |
4.3.1 Limited access to antimalarial drugs in remote areas |
4.3.2 High costs associated with antimalarial drugs |
4.3.3 Potential side effects and resistance issues with current antimalarial treatments |
5 Latvia Antimalarial Drugs Market Trends |
6 Latvia Antimalarial Drugs Market Segmentations |
6.1 Latvia Antimalarial Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Latvia Antimalarial Drugs Market Revenues & Volume, By Quinine, 2021-2031F |
6.1.3 Latvia Antimalarial Drugs Market Revenues & Volume, By Chloroquine, 2021-2031F |
6.1.4 Latvia Antimalarial Drugs Market Revenues & Volume, By Proguanil, 2021-2031F |
6.1.5 Latvia Antimalarial Drugs Market Revenues & Volume, By Mefloquine, 2021-2031F |
6.1.6 Latvia Antimalarial Drugs Market Revenues & Volume, By Pyrimethamine, 2021-2031F |
6.1.7 Latvia Antimalarial Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.2 Latvia Antimalarial Drugs Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Latvia Antimalarial Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021-2031F |
6.2.3 Latvia Antimalarial Drugs Market Revenues & Volume, By Retail Pharmacy, 2021-2031F |
6.2.4 Latvia Antimalarial Drugs Market Revenues & Volume, By E-Commerce & Other Distribution Channel, 2021-2031F |
7 Latvia Antimalarial Drugs Market Import-Export Trade Statistics |
7.1 Latvia Antimalarial Drugs Market Export to Major Countries |
7.2 Latvia Antimalarial Drugs Market Imports from Major Countries |
8 Latvia Antimalarial Drugs Market Key Performance Indicators |
8.1 Percentage increase in the number of diagnosed malaria cases in Latvia |
8.2 Number of healthcare facilities offering antimalarial drugs |
8.3 Investment in research and development of new antimalarial drugs |
8.4 Percentage of the population using preventive measures against malaria |
8.5 Availability of affordable antimalarial drugs in the market |
9 Latvia Antimalarial Drugs Market - Opportunity Assessment |
9.1 Latvia Antimalarial Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Latvia Antimalarial Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Antimalarial Drugs Market - Competitive Landscape |
10.1 Latvia Antimalarial Drugs Market Revenue Share, By Companies, 2024 |
10.2 Latvia Antimalarial Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here